skip navigational links Occupational Safety & Health Administration DOL.gov OSHA.gov DOL.gov
www.OSHA.gov
Dichlorvos (DDVP) Safety and Health Topics:
Dichlorvos (DDVP)

General Description
    Synonyms: 2,2-Dichlorovinyl Dimethyl Phosphate; Vapona; 2,2-Dichlorobinyldimethyl Phosphate; 2,2-dichlorovinyl dimethyl ester phosphoric acid

    OSHA IMIS Code Number: 0850
    IMIS Name History: DDVP prior to 9/1/89

    Chemical Abstracts Service (CAS) Registry Number: 62-73-7

    NIOSH, Registry of Toxic Effects (RTECS) Identification Number: TC0350000

    Department of Transportation Regulation Number (49 CFR 172.101) and Guide: 2783 152

    NIOSH Pocket Guide to Chemical Hazards, Dichlorvos: chemical description, physical properties, potentially hazardous incompatibilities, and more
Exposure Limits
    OSHA Permissible Exposure Limit (PEL) for General Industry: 29 CFR 1910.1000 Z-1 Table -- 1 mg/m3 TWA; Skin

    OSHA Permissible Exposure Limit (PEL) for Construction Industry: 29 CFR 1926.55 Appendix A -- 1 mg/m3 TWA; Skin

    OSHA Permissible Exposure Limit (PEL) for Maritime: 29 CFR 1915.1000 Table Z-Shipyards -- 1 mg/m3 TWA; Skin

    American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV): 0.1 mg/m3 TWA (Inhalable Fraction) (Vapor and Aerosol); Skin; SEN; Appendix A4 - Not Classifiable as a Human Carcinogen; BEI

    National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Limit (REL): 1 mg/m3 TWA; Skin
Health Factors
    International Agency for Research on Cancer (IARC) carcinogenic classification: Group 2B, possibly carcinogenic to humans

    U. S. Energy Protection Agency (EPA) carcinogenic classification: Group B2, probable human carcinogen.

    NIOSH Immediately Dangerous To Life or Health Concentration (IDLH): 100 mg/m3

    Potential symptoms: Miosis, aching eyes; rhinorrhea; headache; tight chest, wheezing, laryngeal spasms; salivation; slurred speech; cyanosis; anorexia, nausea, vomiting, abdominal cramps, diarrhea; involuntary defecation and urination; sweating, muscle fasciculation, paralysis, giddiness, ataxia; convulsions, low blood pressure; cardiac irregularities; skin, eye irritation; skin sensitization, dermatitis.

    Health Effects: Cholinesterase inhibition (HE6); LD50 (oral, rat) 56-80 mg/kg

    Affected organs: Respiratory system, cardiovascular system, CNS, eyes, skin, blood cholinesterase

    Notes: 1) Although no cases of neuropathy from occupational exposure have been reported, cases of a delayed neuropathy following recovery from acute poisoning with dichlorvos have been reported. 2) Exposure is monitored by the measurement of plasma cholinesterase activity (recovers exponentially with a half-life around 12 days) and erythrocyte acetylcholinesterase activity (recovers linearly in about 80 days). 3) One case of persistent asthma (bronchial obstruction) following occupational exposure to dichlorvos has been reported, and in another case, asthma was provoked by exposure to a cat's plastic collar containing dichlorvos.

    Date Last Revised: 05/26/2004

    Literature Basis:
    • NIOSH Pocket Guide to Chemical Hazards: Dichlorvos.
    • International Chemical Safety Cards (WHO/IPCS/ILO): Dichlorvos.
    • EPA Air Toxics Website: Dichlorvos. U.S. Environmental Protection Agency Technology Transfer Network, Feb. 13, 2003.
    • Bryant, D.H.: Asthma due to insecticide sensitivity. Aust. N.Z. J. Med. 15(1): 66-68, 1985.
    • Deschamps, D., Questel, F., Baud, F.J., Gervais, P. and Dally, S.: Persistent asthma after acute inhalation of organophosphate insecticide. Lancet 344(8938): 1712, 1994.
    • Mason, H.J.: The recovery of plasma cholinesterase and erythrocyte acetylcholinesterase activity in workers after over-exposure to dichlorvos. Occup. Med. (Lond.) 50(5): 343-347, 2000.
    • Pohanish, R.P. (editor): Dichlorvos. In, Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 1. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 844-846.
    • Sevim, S., Aktekin, M., Dogu, O., Ozturk, H. and Ertas, M.: Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can. J. Neurol. Sci. 30(1): 75-78, 2003.
    • Vasconcellos, L.F. Leite, A.C. and Nascimento, O.J.: Organophosphate-induced delayed neuropathy: case report. Arq. Neuropsiquiatr. 60(4): 1003-1007, 2002.
Monitoring Methods used by OSHA
    Laboratory Sampling/Analytical Method:

    • sampling media: OSHA Versatile Sampler (OVS-2) - 13 mm XAD-2 tube (270/140 mg sections, 20/60 mesh) with Glass Fiber Filter enclosed
      analytical solvent: Toluene
      maximum volume: 480 Liters   maximum flow rate: 1.0 L/min
      current analytical method: Gas Chromatography; GC/FPD
      method reference: OSHA Analytical Method (OSHA 62)
      method classification: Fully Validated
      note: OSHA personnel may obtain sampling tubes from SLTC.

    Wipe sampling: Yes, with Glass Fiber Filter

    Bulk method: Limit the amount of bulk submitted to one gram or one mL.
* All Trademarks are the property of their respective owners.
 
 Safety and Health
 Topics
 
  Chemical Sampling Information:
  Dichlorvos (DDVP)
  General Description
  Exposure Limits
  Health Factors
  Monitoring
     
     
     
     
     
     
 
 
 
 
 
Back to Top Back to Top www.osha.gov www.dol.gov

Contact Us | Freedom of Information Act | Customer Survey
Privacy and Security Statement | Disclaimers
Occupational Safety & Health Administration
200 Constitution Avenue, NW
Washington, DC 20210
Page last updated: 11/12/2004